Related Experiment Video
Updated: Oct 16, 2025
08:09
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
Published on: June 21, 2021
6.4K
Creating Cell Model 2.0 Using Patient Samples Carrying a Pathogenic Mitochondrial DNA Mutation: iPSC Approach for
Pragya Singh1, Tyler Bahr1, Xiaoxu Zhao1
1Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|October 20, 2021
Summary
Leber's Hereditary Optic Neuropathy (LHON) research benefits from a new induced pluripotent stem cell model. This model allows for the study of retinal ganglion cells, crucial for understanding this mitochondrial disease.
Area of Science:
- Mitochondrial biology
- Neuroscience
- Stem cell research
Background:
- Leber's Hereditary Optic Neuropathy (LHON) is a primary mitochondrial disease affecting the optic nerve.
- Mutations in mitochondrial DNA-encoded respiratory complex I subunits cause LHON.
- Current disease models lack specificity for the affected retinal ganglion cells.
Purpose of the Study:
- To develop a relevant cell model for studying LHON pathogenesis.
- To generate retinal ganglion cells from induced pluripotent stem cells (iPSCs).
- To investigate tissue-specific mechanisms of LHON and identify therapeutic targets.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs).
- Differentiation of iPSCs into retinal ganglion cells.
- Cardiomyocyte differentiation used to confirm iPSC pluripotency.
Main Results:
- A detailed protocol for generating retinal ganglion cells from iPSCs is established.
- Cardiomyocytes were successfully generated, confirming the pluripotency of the iPSCs.
- The developed model is suitable for studying LHON's tissue-specific effects.
Conclusions:
- iPSC-derived retinal ganglion cells provide a valuable model for LHON research.
- This model facilitates the study of molecular mechanisms underlying LHON.
- The protocol aids in identifying novel therapeutic strategies for LHON.
